LogicMark, Inc.

As of November 15, 2016, LogicMark, Inc. is considered a risky investment due to significant losses and negative financial metrics, including a P/E ratio of -0.2290, a Price to Book Value of 0.11, and a stock return of -99.91% over the past year, indicating overvaluation compared to peers.

As of November 15, 2016, LogicMark, Inc. is considered overvalued and risky due to significant financial challenges, a Price to Book Value of 0.11, a concerning EV to EBITDA ratio of 2.03, and a year-to-date return of -99.74% compared to the S&P 500's 2.44%.

As of June 3, 2025, the market trend has shifted to bearish with weak strength, indicated by bearish moving averages, Bollinger Bands, and KST signals, despite some mildly bullish signals from MACD and RSI.

As of March 2022, the management team of LogicMark, Inc. is led by Mr. Vincent Miceli, who serves as Chairman, President, CEO, and CFO, alongside independent directors Dr. Robert Curtis, Dr. Michael D'Almada-Remedios, Maj. Gen. (Retd.) David Gust, and Mr. Daniel Sharkey.

LogicMark, Inc. is a micro-cap technology company specializing in hardware and software security systems for healthcare applications. As of March 2025, it reported net sales of $3 million and a net loss of $2 million, with a market cap of $2.19 million.

As of Jun 18, LogicMark, Inc. has a market capitalization of 2.19 million, with net sales of 9.89 million and a net profit of -9.45 million over the latest four quarters. Shareholder's funds are reported at 12.19 million, and total assets amount to 14.22 million.